Integrating youth mental health into cash transfer programmes in response to the COVID-19 crisis in low-income and middle-income countries.


Journal

The lancet. Psychiatry
ISSN: 2215-0374
Titre abrégé: Lancet Psychiatry
Pays: England
ID NLM: 101638123

Informations de publication

Date de publication:
04 2021
Historique:
received: 18 06 2020
revised: 06 08 2020
accepted: 06 08 2020
pubmed: 8 2 2021
medline: 30 3 2021
entrez: 7 2 2021
Statut: ppublish

Résumé

Social protection measures can play an important part in securing livelihoods and in mitigating short-term and long-term economic, social, and mental health impacts of the COVID-19 pandemic. In particular, cash transfer programmes are currently being adapted or expanded in various low-income and middle-income countries to support individuals and families during the pandemic. We argue that the current crisis offers an opportunity for these programmes to focus on susceptible young people (aged 15-24 years), including those with mental health conditions. Young people living in poverty and with mental health problems are at particular risk of experiencing adverse health, wellbeing, and employment outcomes with long-term consequences. They are also at risk of developing mental health conditions during this pandemic. To support this population, cash transfer programmes should not only address urgent needs around food security and survival but expand their focus to address longer-term mental health impacts of pandemics and economic crises. Such an approach could help support young people's future life chances and break the vicious cycle between mental illness and poverty that spirals many young people into both socioeconomic and mental health disadvantage.

Identifiants

pubmed: 33549174
pii: S2215-0366(20)30382-5
doi: 10.1016/S2215-0366(20)30382-5
pmc: PMC9215313
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

340-346

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Références

Lancet. 2018 Oct 27;392(10157):1553-1598
pubmed: 30314863
Lancet. 2020 May 30;395(10238):1687-1688
pubmed: 32539939
Lancet Child Adolesc Health. 2020 Jun;4(6):416-418
pubmed: 32458805
Int J Epidemiol. 2011 Dec;40(6):1565-76
pubmed: 21737404
Int J Ment Health Syst. 2018 Oct 24;12:61
pubmed: 30386420
J Affect Disord. 2018 Mar 15;229:396-402
pubmed: 29331699
J Adolesc Health. 2016 Feb;58(2):223-9
pubmed: 26576822
World Psychiatry. 2012 Oct;11(3):139-45
pubmed: 23024664
Lancet. 2011 Oct 22;378(9801):1502-14
pubmed: 22008425
BMJ. 2003 Oct 25;327(7421):964
pubmed: 14576248
Soc Psychiatry Psychiatr Epidemiol. 2019 May;54(5):599-606
pubmed: 30456426
Am J Epidemiol. 2014 Jul 1;180(1):45-52
pubmed: 24939978
World Bank Econ Rev. 2009;23(1):57-76
pubmed: 25892838
Lancet. 2009 Jul 25;374(9686):315-23
pubmed: 19589588
PLoS One. 2014 Jan 15;9(1):e85473
pubmed: 24454875
Int J Law Psychiatry. 2014 May-Jun;37(3):245-52
pubmed: 24280316
Lancet Psychiatry. 2020 Feb;7(2):118-119
pubmed: 31653556
Eur Child Adolesc Psychiatry. 2021 Feb;30(2):213-223
pubmed: 32162056
J Child Psychol Psychiatry. 2018 Jun;59(6):703-710
pubmed: 29197100
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2693-8
pubmed: 21262822
Soc Sci Med. 2015 May;132:45-53
pubmed: 25792339
PLoS One. 2013 Jul 26;8(7):e69792
pubmed: 23922801
Soc Sci Med. 2009 Apr;68(7):1322-31
pubmed: 19200631
Demogr Res. 2017;36:1721-1758
pubmed: 29242707
J Health Econ. 2014 Jul;36:1-19
pubmed: 24721206
J Psychosom Res. 2020 Feb 13;131:109966
pubmed: 32087433
Lancet Psychiatry. 2020 Sep;7(9):813-824
pubmed: 32682460
Soc Sci Med. 2010 Aug;71(3):517-528
pubmed: 20621748
Eur J Epidemiol. 2017 Jan;32(1):77-85
pubmed: 27730407
Soc Sci Med. 2019 Mar;225:108-119
pubmed: 30826585
Lancet Child Adolesc Health. 2020 Jun;4(6):421
pubmed: 32302537
Pediatrics. 2019 Aug;144(2):
pubmed: 31262779
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
BMJ Glob Health. 2018 Mar 17;3(2):e000471
pubmed: 29607096
Lancet Psychiatry. 2018 Apr;5(4):357-369
pubmed: 29580610
Int J Soc Psychiatry. 2020 Jun;66(4):317-320
pubmed: 32233719
Lancet. 2017 Jan 14;389(10065):176-185
pubmed: 27988143
J Adolesc Health. 2020 Jul;67(1):135-137
pubmed: 32444197
Cochrane Database Syst Rev. 2017 Nov 15;11:CD011135
pubmed: 29139110

Auteurs

Annette Bauer (A)

Care Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, London, UK. Electronic address: a.bauer@lse.ac.uk.

Emily Garman (E)

Alan J Flisher Centre for Public Mental Health, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.

David McDaid (D)

Care Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, London, UK.

Mauricio Avendano (M)

Department of Global Health & Social Medicine, King's College London, London, UK; Department of Social and Behavioural Sciences, Harvard School of Public Health Boston, Massachusetts, MA, USA.

Philipp Hessel (P)

Escuela de Gobierno Alberto Lleras Camargo, Universidad de Los Andes, Bogotá, Colombia.

Yadira Díaz (Y)

Escuela de Gobierno Alberto Lleras Camargo, Universidad de Los Andes, Bogotá, Colombia.

Ricardo Araya (R)

Centre for Global Mental Health, Health Service & Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Crick Lund (C)

Alan J Flisher Centre for Public Mental Health, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Centre for Global Mental Health, Health Service & Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Paulo Malvasi (P)

Faculdade de Ciências Médicas da Santa Casa de São Paulo, Department of Public Health, São Paulo, Brasil.

Alicia Matijasevich (A)

Faculdade de Medicina FMUSP, Departamento de Medicina Preventiva, Universidade de São Paulo, São Paulo, Brasil.

A-La Park (AL)

Care Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, London, UK.

Cristiane Silvestre Paula (CS)

Programa de Pós-graduação em Distúrbios do Desenvolvimento, Universidade Presbiteriana Mackenzie, São Paulo, Brasil.

Carolina Ziebold (C)

Programa de Pós-graduação em Distúrbios do Desenvolvimento, Universidade Presbiteriana Mackenzie, São Paulo, Brasil.

Annie Zimmerman (A)

Department of Global Health & Social Medicine, King's College London, London, UK; Centre for Global Mental Health, Health Service & Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Sara Evans-Lacko (S)

Care Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH